3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Unknown
1
Sponsor Class
OTHER_GOV
1
Study Type
Interventional
1
Sponsor
Cancer Type
Breast
1
Conditions
Esophageal Neoplasms
2
Solid Tumors
1
Sarcoma
1
Pathologic Complete Response
1
Ovarian Neoplasms
1
Esophageal Squamous Cell Carcinoma
1
Carcinoma, Non-Small-Cell Lung
1
Breast Neoplasms
1
Advanced Triple Negative Breast Cancer
1
Advanced Gastric Adenocarcinoma
1
Interventions
pertuzumab
2
Trastuzumab
2
Docetaxel
2
Carboplatin
2
Epirubicin
1
Albumin-Bound Paclitaxel
1
130-nm albumin-bound paclitaxel
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER_GOV
×
Pathologic Complete Response
×
Albumin-Bound Paclitaxel
×
Clear all
NCT01830244
2017-07-02
Neonab
Barwon Health
Phase 2
Unknown
60 enrolled